[HTML][HTML] Next steps toward eradication of hepatitis C in the era of direct acting antivirals
Results There are major steps that should be taken to eradicate HCV, including (1) the
development of screening strategies, particularly for groups such as intravenous drug users …
development of screening strategies, particularly for groups such as intravenous drug users …
Psychiatric side effects of pegylated interferon‑α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta‑analysis
L Davoodi, B Masoum… - Experimental and …, 2018 - spandidos-publications.com
An estimated 185 million people worldwide are infected with hepatitis C virus (HCV).
Combination therapy with pegylated interferon‑α (peg IFN) and ribavirin is the first line of …
Combination therapy with pegylated interferon‑α (peg IFN) and ribavirin is the first line of …
Navigating Evolving Challenges in Blood Safety
MR Pourkarim - Viruses, 2024 - mdpi.com
Blood safety remains a paramount public health concern, and health authorities maintain a
high level of vigilance to prevent transfusion-transmitted infections (TTIs)[1]. Rigorous …
high level of vigilance to prevent transfusion-transmitted infections (TTIs)[1]. Rigorous …
Diagnostic approach to elucidate the efficacy and side effects of direct-acting antivirals in HCV infected patients
Introduction: The conventional interferon therapy of hepatitis C virus has been substituted
substantially with sofosbuvir and daclatasvir due to constraints in efficacy and tolerability …
substantially with sofosbuvir and daclatasvir due to constraints in efficacy and tolerability …
[HTML][HTML] The course of hepatitis C infection and response to anti-viral therapy in patients with thalassemia major and hepatitis C infection: a longitudinal, prospective …
Background The course of hepatitis C infection (HCV) in patients with thalassemia has not
been adequately studied, and management has not been optimized. The current …
been adequately studied, and management has not been optimized. The current …
WITHDRAWN: Low dose ribavirin for treatment of HCV infected thalassemia major patients: New indications for combination therapy
BACKGROUND & AIMS: Treatment guidelines contraindicate ribavirin for treatment of
hepatitis C virus (HCV) infection in thalassemia major patients. Nevertheless, the current …
hepatitis C virus (HCV) infection in thalassemia major patients. Nevertheless, the current …
The effectiveness of sofosbuvir and daclatasvir in the treatment of hepatitis C in thalassaemia major patients and their effect on haematological factors
Context: Patients with thalassaemia are at risk of infections such as hepatitis C virus (HCV)
due to their repeated blood transfusions; meanwhile, the treatment of thalassaemia patients …
due to their repeated blood transfusions; meanwhile, the treatment of thalassaemia patients …
[PDF][PDF] Efficacy and safety of generic sofosbuvir/ledipasvir fixed-dose combination in Iranian patients with chronic hepatitis C virus infection
Background: Hepatitis C virus (HCV), as a global health concern, has infected around 1.6%
of the world population. Introduction of direct-acting antiviral regimens such as …
of the world population. Introduction of direct-acting antiviral regimens such as …
[HTML][HTML] Interferon lambda 4 polymorphism predicts sustained viral response in hepatitis C virus patients irrespective of hepatitis C virus genotypes, ethnicity or …
Q Wu, C Wang, EQ Chen, H Tang, ZZ Li, XZ Lei - Hepatitis Monthly, 2015 - ncbi.nlm.nih.gov
Results: Ten studies involving 4765 patients were included in the analysis. Of overall
studies, SVR was more frequent in TT/TT genotype compared to TT/ΔG+ ΔG/ΔG (OR= 4.439 …
studies, SVR was more frequent in TT/TT genotype compared to TT/ΔG+ ΔG/ΔG (OR= 4.439 …
Long-Term Follow-Up of Thalassemia Major Patients with Hepatitis C Virus Treated with Sofosbuvir and Daclatasvir: A Cohort Study
Background Treatment of Chronic Hepatitis C virus (HCV) infection in patients suffering from
hereditary β-thalassemia major is a concern due to drug complications and liver malfunction …
hereditary β-thalassemia major is a concern due to drug complications and liver malfunction …